TPCW
BNTX icon

TD Private Client Wealth’s BioNTech BNTX Stock Holding History

TD Private Client Wealth’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3
Closed -$296 – 1649
2025
Q3 		$296 Buy
+3
New +$321 ﹤0.01% 1492
2024
Q3 		– Sell
-927
Closed -$74.5K – 1283
2024
Q2 		$74.5K Sell
927
-6
-0.6% -$548 ﹤0.01% 737
2024
Q1 		$86.1K Sell
933
-58
-6% -$5.56K ﹤0.01% 714
2023
Q4 		$105K Buy
+991
New +$99.9K ﹤0.01% 682
2022
Q1 		– Sell
-7
Closed -$1.8K – 1275
2021
Q4 		$1.8K Buy
+7
New +$1.92K ﹤0.01% 1025

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TD Private Client Wealth's BNTX Position: Q4 2025 in Review

TD Private Client Wealth sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 3 shares — an estimated $296 sold.

TD Private Client Wealth first reported a position in BNTX in Q4 2021 and held it in 5 quarters. The position peaked at $105K in Q4 2023. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • TD Private Client Wealth reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • TD Private Client Wealth sold 3 BioNTech shares in Q4 2025, an estimated $296.
  • TD Private Client Wealth first reported a position in BioNTech in Q4 2021 and held it in 5 quarters.
  • TD Private Client Wealth's BioNTech position peaked at $105K in Q4 2023.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on TD Private Client Wealth's 13F filing for Q4 2025, filed 5 Feb 2026.